Cartalax 20mg

Description

Description

Cartalax (Ala-Glu-Asp) is a synthetic tripeptide bioregulator developed in Russian peptide research, structurally similar to type XI collagen sequences. Classified as a cytogenetic peptide, it is believed to bind directly to DNA in the cell nucleus, modulating gene expression in cartilage and connective tissue cells. Research focuses on chondrocyte function restoration, extracellular matrix renewal, and cellular anti-aging mechanisms. Currently for research use only.

PURITY

99% HPLC

RUO

Research Use Only
Not for human or veterinary use.

Price: $75.00

Epigenetic Chondrocyte Regulation — Rather than acting through surface receptors, Cartalax is hypothesized to bind directly to specific DNA sequences in the cell nucleus, modulating gene expression in chondrocytes to support cartilage homeostasis, structural protein synthesis, and extracellular matrix stability.
Cartilage Regeneration & Joint Support — Preclinical studies show Cartalax may restore chondrocyte function, stimulate extracellular matrix renewal, and support cartilage resilience under mechanical and metabolic stress — making it a candidate for research into osteoarthritis and age-related joint degeneration.
Cellular Senescence Modulation — Research indicates Cartalax may downregulate key aging markers (p16, p21, p53) while upregulating SIRT6 — a longevity-associated enzyme involved in chromatin remodeling — positioning it as a tool for studying cellular senescence and connective tissue aging pathways.
Broad Connective Tissue Activity — Beyond cartilage, studies suggest Cartalax may influence fibroblast proliferation, kidney cell renewal, and oxidative stress regulation, reflecting a wide tissue-repair profile consistent with other Russian-origin bioregulatory peptide bioregulators like Epithalon and Pinealon.